MedPath

Q-switched Neodymium-doped yttrium aluminium garnet (Nd:YAG) 532 nm nanosecond laser vs. Nd:YAG 532 nm picosecond laser for the treatment of solar lentigines in Asians

Phase 4
Completed
Conditions
Solar lentigine 2 lesions on the arms
solar lentigine
picosecond laser
Registration Number
TCTR20171129001
Lead Sponsor
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

-solar lentigines 2 lesions, at least 5 mm in diameter on the arms
-able to comply with treatment regulations
-able to attend every appointment assigned

Exclusion Criteria

-having photosensitive dermatoses
-currently using photosensitizing agents
-being pregnant or lactating woman
-currently/previously having skin cancers
-having a history of keloid/hypertrophic scars

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement score 6 and 10 weeks after last treatment Dermatologist evaluation using grading scale of 1 to 5, Luminance measured by using Chromameter CR-2
Secondary Outcome Measures
NameTimeMethod
Side effects 6 and 10 weeks after treatment Assessed by dermatologists and patient's feedbacks (e.g. postinflammatory hyperpigmentation, postinf
© Copyright 2025. All Rights Reserved by MedPath